X-group (possible homology)

365 Crambin-like

Ligands and drugs

85
Member domains
25
with ligand contacts (≤ 4 Å)
29.4% of members
24
with DrugDomain annotations
28.2% of members
17
with a DrugBank compound
20.0% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

3
Proteins with classified ligands
4
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Benzenoids10.24.62×not tested
Organic acids and derivatives10.52.19×not tested
Organic oxygen compounds10.61.70×not tested
Homogeneous non-metal compounds10.61.57×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00133SERSerine2
DB03120TSUp-Toluenesulfonic acid2
DB02606SBT2-Butanol1

Most frequently bound compounds

PDB ligandNameDomains in contact
CLCHLORIDE ION7
NAmetalSODIUM ION6
SERSERINE2
TSUPARA-TOLUENE SULFONATE2
SBT2-BUTANOL1